Episode 174: MSVirtual2020 Research Recap with Dr. Bruce Bebo

Episode 174: MSVirtual2020 Research Recap with Dr. Bruce Bebo

Publication date: Dec 28, 2020

In this episode of RealTalk MS, we’re re-visiting my conversation with Dr. Bruce Bebo, the Executive Vice-President of Research at the National MS Society, about some of the most interesting research announcements made during the MSVirtual2020 conference. This is one of my favorite conversations of the entire year, and you’ve made it this year’s most downloaded and listened to RealTalk MS episode. We have a lot to talk about! Are you ready for RealTalk MS??! Happy New Year! :23 My interview with Dr. Bruce Bebo :39 Share this episode 27:04 Have you downloaded the FREE RealTalk MS app? 27:24 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/174 ADD YOUR VOICE TO THE CONVERSATION I’ve always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.comPhone: (310) 526-2283 And don’t forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn’t allow you to click on these links, you’ll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Give RealTalk MS a Rating and Review National MS Society’s Ask An MS Expert Video Replay What You Need to Know About Coronavirus (COVID-19) National MS Society COVID-19 Response Fund Join the RealTalk MS Facebook Group Download the RealTalk MS App for iOS Download the RealTalk MS App for Android Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 174 Guests: Dr. Bruce Bebo Tags: MS, MultipleSclerosis, MSResearch, MSSociety, MSActivist, COVID19, MSVirtual2020, RealTalkMS Privacy Policy

Concepts Keywords
Acronym Nervous systems
Aging Web browser
Air Pharmaceutical
Alzheimer Healthcare use
Android Speed solutions
Anemia Healthcare providers
Apple App Store Particular disease
Auras Preventable disease
Austria Parkinson’s disease
Bebo Inflammatory markers
Biomarker Fatigue
Biomarkers Obesity
Blood MS
Brain Infections
British Columbia Severe cova disease
Bruton Sleep disorder
Calorie Restriction Cardiovascular disease
Cambridge Diabetes
Canadian Alzheimer’s disease
Cardiovascular Pain
Catcher News disease
Central Nervous System Neurodegenerative diseases
Cerebral Spinal Fluid Inflammation
Clinical Trial Sleep disorders
Clinical Trials Anemia
Coconut Creative works
Comber Television shows
Congress Television series
Coronavirus You
Cove Therapy
Diabetes 9
Disability Smartphone
Drone Cell signaling
Endogenous Android
Europe Stem cells
Evolution
Exogenous
Facebook
Fatigue
FDA
Filament
Genesis
Glia
Glial
Glial Cells
Google Play Store
Happiness
Healthcare
Iemma
Immune Reaction
Immune System
Inflammation
Inhibitor
IOS
Island
John Hope
Jonah
Kindness
Macedonian
Masset
Metformin
Milan
Mississippi
Morbidity
Myelin
Mylan
Nerve
Nervous System
Neurodegenerative Diseases
Nib
Obesity
Okra
Pain
Parkinson
Pharmaceutical Companies
Podcast
Point Groups
Prize
Progressive
Receptor
Ring
Robin
Roxanne
San Rafael
Signaling Molecule
Sleep Disorder
Sleep Disorders
Smartphone
Society
Spinal Cord
Stem Cells
Stiffness
Tel Aviv
Thes
Transplant Rejection
Twitter
Tyrosine
United States
Vice President
Vienna
Virtual Meeting
Vis
XO

Semantics

Type Source Name
drug DRUGBANK Coenzyme M
drug DRUGBANK Methyltestosterone
disease MESH Privacy
disease MESH development
drug DRUGBANK Nonoxynol-9
drug DRUGBANK L-Tyrosine
disease MESH inflammation
drug DRUGBANK Medical air
disease MESH infections
disease MESH neurodegenerative diseases
pathway REACTOME Neurodegenerative Diseases
disease MESH nerve degeneration
disease MESH aging
drug DRUGBANK Methionine
drug DRUGBANK Metformin
drug DRUGBANK Esomeprazole
disease MESH diagnosis
disease MESH sleep disorders
disease MESH anemia
disease MESH community
drug DRUGBANK Tropicamide
disease MESH risk factors
disease MESH cardiovascular disease
disease MESH obesity
disease MESH Multiple Sclerosis
disease MESH auras
disease MESH death

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *